Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
395
-
Total 13F shares, excl. options
-
73.5M
-
Shares change
-
+279K
-
Total reported value, excl. options
-
$11.8B
-
Value change
-
+$154M
-
Put/Call ratio
-
0.87
-
Number of buys
-
207
-
Number of sells
-
-163
-
Price
-
$160.34
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2020
482 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2020.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 395 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.5M shares
of 106M outstanding shares and own 69.54% of the company stock.
Largest 10 shareholders include FMR LLC (7.82M shares), VANGUARD GROUP INC (7.12M shares), BlackRock Inc. (5.37M shares), Capital Research Global Investors (4.7M shares), SANDS CAPITAL MANAGEMENT, LLC (4.34M shares), JANUS HENDERSON GROUP PLC (3.62M shares), STATE STREET CORP (1.84M shares), Avoro Capital Advisors LLC (1.68M shares), JPMORGAN CHASE & CO (1.58M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.57M shares).
This table shows the top 395 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.